SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced today that it has ...

Tia Harmon (left) is a Technical Product Sales Specialist in the cell and gene therapy (CGT) space at PHC Corporation of North America (PHCNA; IL, USA) with a background in cancer research. In this ...

Cell culture is a complex and involved process. Its success relies on the balance of many important process parameters to provide ideal process conditions for optimal cell growth, maintenance, and ...

Building on its success in developing continuous production at pilot-scale with the WuXiUP™ platform, WuXi Biologics has further enhanced the technology to achieve automated continuous drug substance ...

The Integral (area under the curve) of Viable Cell Concentration (IVCC), also referred to as the Integral of Viable Cell Density (IVCD), is a key calculated metric in cell culture operations. The IVCC ...